98%
921
2 minutes
20
Background: Calcified nodules (CNs) remain a major challenge in percutaneous coronary intervention (PCI). We sought to compare procedural and clinical outcomes after orbital atherectomy (OA) versus intravascular lithotripsy (IVL)-facilitated PCI in patients with CNs.
Methods: We identified patients with optical coherence tomography (OCT)-defined CNs who underwent PCI with either OA or IVL between 2012 and 2022 and had both pre- and post-PCI OCT images available. The imaging end point was the minimal stent area on final post-PCI OCT. The clinical end point was 2-year target-lesion failure, a composite of cardiac death, target-vessel myocardial infarction, or clinically driven target-lesion revascularization. A multivariable Cox proportional hazards regression model was used to estimate hazard ratio and 95% CI. Sensitivity analyses were performed using propensity score matching, incorporating covariates such as age, sex, diabetes, and pre-PCI calcium burden assessed by OCT (length, arc, and thickness).
Results: Among 4856 patients with evaluable pre- and post-PCI OCT images, 493 patients (10.2%) had CNs, and 167 patients underwent PCI with either OA (n=83) or IVL (n=84). The 2 groups had similar baseline demographic and lesion characteristics. After PCI, final minimal stent area was comparable between the 2 groups (OA, 5.6 mm [interquartile range, 4.8-6.7] versus IVL, 5.5 mm [interquartile range, 4.8-7.0]; =0.75). At a median follow-up of 2.4 years, there was no difference in target-lesion failure between the OA and IVL groups (12.0% versus 9.8%, respectively; log-rank =0.64; adjusted hazard ratio, 1.20 [95% CI, 0.43-3.36]; =0.74). Overall results remained consistent in the propensity score-matched population (n=68 per group), with similar minimal stent area (5.6 mm [4.8-6.7] versus 5.5 mm [4.7-6.8]; =0.73) and comparable 2-year target-lesion failure rate (9.8% versus 8.8%; log-rank =0.82).
Conclusions: In patients with OCT-defined CNs, OA- and IVL-assisted PCI resulted in comparable post-PCI minimal stent area and 2-year clinical outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.125.015254 | DOI Listing |
Adv Healthc Mater
September 2025
Department of Biomedical Engineering, University of Houston, Houston, TX, 77204, USA.
Neurogenic bladder and lower urinary tract (LUT) dysfunctions encompass a wide variety of urinary disorders resulting from nervous system impairments. Unfortunately, conventional treatments are still limited and can have significant complication rates, especially when stent implantations or other surgical procedures are involved. Therefore, there is a critical need to develop novel therapeutic strategies and pharmacological approaches to address these challenging urological conditions.
View Article and Find Full Text PDFTrauma Case Rep
October 2025
Department of Trauma Center, Shonan Kamakura General Hospital, Japan.
Autologous vein grafting is a common method for revascularization in cases of traumatic limb arterial injuries. However, no clear guidelines have been established regarding the use of tourniquets following vascular reconstruction. We report a case of graft thrombosis that occurred during a planned orthopedic surgery one week after the initial revascularization.
View Article and Find Full Text PDFJ Robot Surg
September 2025
Consultant Urological Surgeon, Royal Surrey NHS Foundation Trust, Guildford, UK.
The gold standard treatment for muscle-invasive bladder cancer (MIBC) still is radical cystectomy. Thanks to better peri-operative results than open surgery, robotic-assisted radical cystectomy (RARC) has become somewhat well-known. Though they are linked with problems like infection, pain, and higher healthcare expenses, conventionally ureteral stents are used during urinary diversion to minimize anastomotic leaks and strictures.
View Article and Find Full Text PDFIntroduction: Bladder cancer in patients with ureteral anomalies presents unique surgical challenges, particularly regarding urinary diversion. This case highlights a novel approach to uretero-ileal anastomosis in a patient with duplicated right ureters undergoing radical cystectomy.
Case Presentation: A 65-year-old man with cT2N0M0 bladder cancer underwent transurethral resection of the bladder tumor, revealing a complete duplex right ureter.
Catheter Cardiovasc Interv
September 2025
University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
First-generation drug-eluting stents (DES) with thick polymers may contribute to local vascular inflammation and late stent thrombosis. Thinner-strut DES, particularly those with biodegradable polymers and ultrathin struts, aim to reduce this risk by minimizing flow disturbance and vascular injury. Nonetheless, the long-term safety and efficacy of ultrathin biodegradable polymer sirolimus-eluting stents (BP-SES) compared to durable polymer everolimus-eluting stents (DP-EES) are still uncertain.
View Article and Find Full Text PDF